Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
10/1995
10/18/1995EP0677060A1 Peptide inhibitors of cell adhesion
10/18/1995EP0677059A1 Endothelin converting enzyme inhibitors
10/18/1995EP0677057A1 Biopolymer synthesis utilizing surface activated, organic polymers
10/17/1995US5459240 Genetic engineering of proteins
10/17/1995US5459238 Stimulate cytototoxic T lymphocyte immunity by interacting with human leucocyte antigen; possible AIDS vaccine
10/17/1995US5459236 Vasoactive vasotocin derivatives
10/17/1995US5459077 By charge transfer interaction
10/17/1995CA1337372C Inhibition of bacterial ribonucleotide reductase
10/12/1995WO1995027074A1 Antifungal and anti-pneumocystis compounds, compositions containing such compounds, and methods of use
10/12/1995WO1995027061A1 Protein tyrosine kinase agonist antibodies
10/12/1995WO1995026981A2 Peptides having farnesyl transferase inhibiting properties and strain of genus streptomyces for producing same
10/12/1995WO1995026980A2 Haptenated peptides and uses thereof
10/12/1995WO1995026979A1 Cytotoxic t-cell lymphocyte ('ctl') activity regulation by class i mhc peptides
10/12/1995WO1995022996A3 Peptide-chelator conjugates
10/12/1995WO1995022991A3 Block copolymers
10/12/1995CA2187193A1 Cytotoxic t-cell lymphocyte ("ctl") activity regulation by class i mhc peptides
10/12/1995CA2186873A1 Haptenated peptides and uses thereof
10/12/1995CA2184756A1 Peptides having farnesyl transferase inhibiting properties and strain of genus streptomyces for producing same
10/11/1995EP0676411A2 Peptides and pseudopeptides derived from tachykinine, their preparation and their pharmaceutical compositions
10/11/1995EP0675953A1 Soluble peptides having constrained, secondary conformation in solution and method of making same
10/11/1995EP0675903A1 Bone resorption assay
10/11/1995EP0675902A1 Endothelin antagonists
10/11/1995EP0675901A1 Difluoro-pentapeptide derivative anti-inflammatory agents
10/11/1995EP0675731A1 Treatment of cytomegalovirus infection
10/11/1995CN1109780A Sustained-release preparation of anti-endothelin substance
10/11/1995CN1029976C Process for reducing methionine sulfoxide residues
10/10/1995US5457182 An isolated, purified homogeneous polypeptide having a specific binding the immunosuppressant, but not cyclosporine
10/10/1995US5457177 Thrombin receptor radioligands
10/05/1995WO1995026506A1 Methods for detecting calpain activation and indentifying calpain inhibitors
10/05/1995WO1995026361A1 Vpr AND Vpx PROTEINS OF HIV
10/05/1995DE4411025A1 New lipopeptide A1437 derivs. with modified acyl gp.
10/05/1995CA2186398A1 Vpr and vpx proteins of hiv
10/05/1995CA2185141A1 Methods for detecting calpain activation and indentifying calpain inhibitors
10/04/1995EP0674659A1 Peptides and vaccines derived from nematode tubulin
10/04/1995EP0674655A1 Acyclic peptide analogs of the atrial natriuretic peptide, process for producing the same and their use
10/04/1995EP0674654A1 Acyclic, sulphureous peptides as analogs of the atrial natriuretic peptide
10/04/1995EP0674652A1 Dolostatin analog
10/04/1995EP0674632A1 Aminoacid derivatives of heterocycles as protein kinase c inhibitors
10/03/1995US5455228 Peptidase resistant thrombin receptor peptide ligand
10/03/1995US5455227 Biologically active lipoprotein and its use
10/03/1995US5455179 Quantitative analysis using polypeptide
10/03/1995US5455168 α-glycosyl trehalose-forming enzyme
10/03/1995US5455158 Imaging fibrin-containing substance using labeled polypeptide imaging agent which binds to fibrin
09/1995
09/28/1995WO1995025749A2 Eating suppressant peptides
09/28/1995WO1995025741A1 Gnrh antagonists
09/28/1995WO1995025740A1 Isolated peptides derived from mage tumor rejection antigen precursors which complex with hla-a2 molecules
09/28/1995WO1995025739A1 Isolated, mage-3 derived peptides which complex with hla-a2 molecules and uses thereof
09/28/1995WO1995025720A1 Piperidyl-4-substituted thyrosine derivatives as scintigraphic imaging agents for the diagnosis of thrombosis
09/28/1995WO1995025530A1 Isolated tumor rejection antigen precursor mage-2 derived peptides, and uses thereof
09/28/1995CA2186006A1 Isolated tumor rejection antigen precursor mage-2 derived peptides, and uses thereof
09/28/1995CA2186005A1 Isolated, mage-3 derived peptides which complex with hla-a2 molecules and uses thereof
09/28/1995CA2185710A1 Gnrh antagonists
09/28/1995CA2185450A1 Eating suppressant peptides
09/27/1995EP0674178A2 Cyclosporin immunoassay
09/27/1995EP0674004A1 MSRV1 virus and pathogenic and/or infections agent MSRV2 linked to multiple sclerosis, their nucleic components and their applications
09/27/1995EP0673948A1 Pepticles derived from a retrovirus of the HIV-group and their use
09/27/1995EP0673418A1 Monoclonal antibodies directed against the microtubule-associated protein tau, hybridomas secreting these antibodies, antigen recognition by these monoclonal antibodies and their applications
09/27/1995EP0673388A1 Double chain peptide compounds having hemoregulatory activity
09/27/1995EP0673387A1 Materials and methods for control of pests
09/27/1995EP0673386A1 Methods and compositions for detecting anti-hepatitis e virus activity
09/27/1995EP0673254A1 6-position modified decapeptide lhrh antagonists
09/27/1995EP0593460B1 Method and apparatus for biopolymer synthesis
09/27/1995EP0348490B1 Treatment of type 2 diabetes mellitus
09/26/1995US5453417 Process for the phosphorylation of insulin and product produced thereby
09/21/1995WO1995025122A1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis c virus
09/21/1995WO1995024916A1 Retropeptides, antibodies thereto, and uses thereof for vaccination and in vitro diagnosis
09/21/1995WO1995024915A1 Product and process for regulating signal transduction pathways
09/21/1995WO1995021858A3 Mosaic polypeptide and methods for detecting the hepatitis e virus
09/21/1995CA2184631A1 Product and process for regulating signal transduction pathways
09/20/1995EP0672680A1 Novel peptide
09/20/1995EP0672648A1 Threo-3-amino-2-hydroxypentanoic acid and threo (2R,3S), (2S,3R)-3-(p-methoxy-benzyloxycarbonyl) amino-2-hydroxy-pentanoic acid
09/20/1995EP0672134A1 Peptides useful for inducing tolerance
09/20/1995EP0672059A1 CYCLIC COMPOUNDS LINKED BY A HETEROCYCLIC RING USEFUL AS INHIBITORS OF PLATELET GLYCOPROTEIN IIb/IIIa
09/20/1995EP0672055A1 Neuropeptide y antagonists
09/20/1995EP0672054A1 A novel molecule which inhibits neuropeptide tyrosine biological function
09/20/1995EP0672053A1 Treatment of septic shock with conjugated biologically active peptides
09/20/1995EP0671949A1 USE OF $g(b)-CELL-TROPIN (ACTH 22-39) ANTAGONISTS IN THE TREATMENT OF TYPE II DIABETES AND ASSOCIATED DISEASES
09/20/1995EP0671946A1 Immunoreactive peptides from epstein-barr virus
09/20/1995EP0671941A1 Bradykinin antagonists
09/20/1995EP0671939A1 Treatment of dermatological malignancies with biologically active peptides
09/20/1995EP0671935A1 Amino acid conjugates of cyclohexapeptidyl amines
09/20/1995EP0671931A1 Hemoregulatory peptides
09/20/1995EP0671930A1 Prophylaxis and treatment of adverse oral conditions with biologically active peptides
09/20/1995EP0671928A1 Synthesis of n-substituted oligomers
09/20/1995EP0536343B1 Targeted polymeric conjugates of cyclosporin and method for their preparation
09/19/1995US5451658 Antagonists of human gamma interferon
09/14/1995WO1995024424A1 Cyclic peptide lhrh antagonists
09/14/1995WO1995024423A1 Insect neuropeptides
09/14/1995WO1995024422A1 Bradykinin antagonist peptides incorporating n-substituted glycines
09/14/1995WO1995024419A1 Methods and materials for identifying inhibitors of molecular interactions mediated by sh3 domains
09/14/1995WO1995024222A1 Cyclic polycationic polymer-oligonucleotide conjugates and methods for preparing same
09/14/1995WO1995024220A1 Bispecific molecules having clinical utilities
09/14/1995DE4408116A1 New viprolide derivs.
09/14/1995CA2184824A1 Bradykinin antagonist peptides incorporating n-substituted glycines
09/14/1995CA2183568A1 Insect neuropeptides
09/13/1995EP0671413A1 Somatostatin analogs for preventing NSAID-induced ulcers
09/13/1995EP0670901A1 Polypeptide fragment capable of inducing neutralising antibodies against feline immuno-deficiency virus
09/13/1995EP0670751A1 Improved sensor membranes
09/13/1995EP0670729A1 Treating retinal neuronal disorders by the application of insulin-like growth factors and analogs
09/13/1995EP0670728A1 Lipophilic peptide-based carriers for targeted drug delivery using rational drug-binding design
1 ... 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 ... 423